Autres langues Eli Lilly and Company Deutsche Boerse AG

Actions

Temps réel estimé Tradegate Autres places de cotation 14:56:06 02/05/2024			Varia. 5j.	Varia. 1 janv.
730,4 ^EUR	+0,47 %		+5,12 %	+38,42 %

14:24	Novo Nordisk : Les prix de Wegovy et d'Ozempic ont baissé aux États-Unis au premier trimestre	RE
08:03	Novo Nordisk dépasse les attentes au T1 et relève ses perspectives	RE

Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1	14:24
Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast	07:42
Obesity drugmaker Novo Nordisk's Q1 profit beats forecast	07:32
British pharmacies vie for weight-loss patients with drug price cuts	07:03
Amgen investors await weight-loss drug data	01/05
Danish Medicines Agency Says Type 2 Diabetes Patients Should Start Treatment With 'Cheaper' Drugs	01/05
Amgen investors await weight-loss drug data	01/05
Dinamarca restringirá el uso de Ozempic y otros GLP-1 para tratar la diabetes tipo 2	01/05
Equity Markets Drop Ahead of Fed Rate Decision	30/04
Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024	30/04
US Equity Markets Close Down Tuesday After Higher Wage Data	30/04
MÄRKTE USA/Anleger bekommen vor Fed-Auftritt kalte Füße	30/04
Sector Update: Health Care Stocks Mixed Late Afternoon	30/04
Equity Markets Down Ahead of Amazon Earnings	30/04
Sector Update: Health Care Stocks Gain in Afternoon Trading	30/04
Sector Update: Health Care	30/04
Wall Street stocks fall as markets weigh strong wage data, Fed meeting	30/04
Trending : Eli Lilly Reports Strong Sales of Weight-Loss, Diabetes Drugs	30/04
MÄRKTE USA/Neue Preisdaten drücken auf die Stimmung	30/04
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues	30/04

Aucun résultat pour cette recherche

David Ricks, PDG d'Eli Lilly : Un marche de plus d'un milliard de personnes

Le 12 mars 2024 à 19:47